Author

Ken Sugimoto

First Department of Medicine, Hamamatsu University School of Medicine - Cited by 6,959 - gastroenterology

Biography

Dr. Ken Sugimoto is an Associate professor in the First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan. His study interests major on Medicine. In recent years, he has studied several on gastroenterology, Pepsinogen, Gastricatrophy. Currently, Dr. Ken is the author/editors/reviewer in several international journals. He published 10 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
H Nakase, M Uchino, S Shinzaki, M Matsuura, K Matsuoka, T Kobayashi, ...Journal of gastroenterology 56 (6), 489-526, 2021202
188
2021
C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis
N Ishida, T Higuchi, T Miyazu, S Tamura, S Tani, M Yamade, M Iwaizumi, ...Scientific Reports (1), 12431, 2021202
11
2021
Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia
T Suzuki, T Higuchi, T Kagami, T Uotani, M Yamade, S Tani, Y Hamaya, ...European Journal of Clinical Pharmacology 77 (7), 971-97, 2021202
8
2021
Real-world efficacy and safety monitoring for predicting continuation of tofacitinib therapy in patients with ulcerative colitis
N Ishida, T Miyazu, S Tamura, S Tani, M Yamade, M Iwaizumi, Y Hamaya, ...Digestive Diseases and Sciences 6 (8), 3984-3992, 2022202
7
2022
Prostaglandin E-major urinary metabolite predicts relapse in patients with ulcerative colitis in clinical remission
N Ishida, K Sugiura, T Miyazu, S Tamura, S Suzuki, S Tani, M Yamade, ...Clinical and translational gastroenterology 11 (12), 2020202
6
2020
Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse
N Ishida, S Onoue, T Miyazu, S Tamura, S Tani, M Yamade, M Iwaizumi, ...International Journal of Colorectal Disease 3, 21-270, 2021202
6
2021
A consensus statement on health‐care transition for childhood‐onset inflammatory bowel disease patients
H Kumagai, T Shimizu, I Iwama, SI Hagiwara, T Kudo, M Takahashi, ...Pediatrics International 64 (1), e1241, 2022202
5
2022
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease
M Kato, K Sugimoto, K Ikeya, R Takano, A Matsuura, T Miyazu, N Ishida, ...Plos one 16 (7), e02558, 2021202
4
2021
Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
N Ishida, T Miyazu, S Tamura, S Tani, M Yamade, M Iwaizumi, Y Hamaya, ...World Journal of Gastroenterology 27 (22), 3109, 2021202
4
2021
Prevalence of UL97 gene mutations and polymorphisms in cytomegalovirus infection in the colon associated with or without ulcerative colitis
S Tamura, S Osawa, N Ishida, T Miyazu, S Tani, M Yamade, M Iwaizumi, ...Scientific Reports 11 (1), 1676, 2021202
3
2021
Improvement in ulcerative colitis by administration of Benralizumab for comorbid refractory bronchial asthma: a novel clinical observation
K Sugimoto, S Fujita, T Miyazu, N Ishida, S Tani, M Yamade, Y Hamaya, ...Inflammatory Bowel Diseases 27 (1), e-e4, 2021202
3
2021
Nicotinic acetylcholine receptor agonist reduces acute lung injury after renal ischemia-reperfusion injury by acting on splenic macrophages in mice
D Goto, S Nagata, Y Naito, S Isobe, T Iwakura, T Fujikura, N Ohashi, ...American Journal of Physiology-Renal Physiology 22 (5), F540-F552, 2022202
3
2022
Dilated main pancreatic duct can be a negative predictor of pancreatitis related to biliary SEMS insertion across the papilla
M Umemura, E Shimura, Y Asai, A Tsuji, M Nishino, Y Takahashi, ...Scandinavian Journal of Gastroenterology 56 (7), 865-869, 010
2
2021
Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis
N Ishida, S Tamura, T Miyazu, S Tani, M Yamade, M Iwaizumi, Y Hamaya, ...Scientific Reports 11 (1), 1605, 010
2
2021
Risk factors for totally implantable central venous access port-related infection in patients with malignancy
S Furuhashi, Y Morita, S Ida, R Muraki, R Kitajima, K Suzuki, M Takeda, ...Anticancer Research 41 (3), 1547-1553, 010
2
2021
Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report
N Ishida, T Miyazu, S Tamura, S Suzuki, S Tani, M Yamade, M Iwaizumi, ...World Journal of Gastroenterology 6 (45), 763, 000
2
2020
Microsatellite frameshift variants in SGO1 of gastric cancer are not always associated with MSI status
Microsatellite frameshift variants in SGO of gastric cancer are not always associated with MSI statusT Sugiyama, M Iwaizumi, T Taniguchi, S Suzuki, S Tani, M Yamade, ...Journal of Clinical Pathology 74 (6), 386-390, 20220
1
2021
Analysis of water balance for perioperative management in coronary artery bypass grafting
Y Ochiai, T Watanabe, I Ohashi, H Katayama, N Ishida, M Hayashi, ...Kawasaki Med. J 47, 55-62, 20220
1
2021
Lymphocyte-to-monocyte ratio is a short-term predictive marker of ulcerative colitis after induction of advanced therapy
N Ishida, Y Asai, T Miyazu, S Tamura, S Tani, M Yamade, M Iwaizumi, ...Gastroenterology report 0, goac025, 2022202
1
2022

Referred From: https://scholar.google.com/citations?hl=en&user=IlKsBCEAAAAJ

Cited by
Citations 6959
h-index 34
i10-index 88
Recommended Journals
Open Access Journals